Aehr Test Systems is an upper-tier opportunity for anyone who believes the AI build-out is still in its early innings, after giving back nearly all of its 40% post-earnings gain. Guidance of about $140M at the midpoint implies roughly 170% growth over FY26 at about 20x sales, not cheap but a big opportunity alongside a $100M backlog. Many names map back to Aehr. x.com 

Aehr Test Systems may be the best of breed in chip equipment, with the strongest year-over-year EPS growth in the space as a maker of chip test equipment. It is no longer the momentum play it was, but today's push off its short-term low on massive volume looks like the real deal. x.com 

Aehr Test Systems is key to AI manufacturing and can even be a bottleneck, but at almost 20x revenue through 2028 at the current price, it is stratospherically priced. The risk is giant if something goes wrong for the company or for the AI ramp, and even a slowdown could be deadly at such high valuations. Tech moats are not the same as financial moats. x.com 

AI semiconductor stocks are falling because valuations priced in too much growth beyond 2026-27, not because fundamentals are worsening. With the sector ETF up more than 100% year to date at one point, Q2 earnings couldn't meet those expectations, and a crowded trade is deleveraging as everyone races for the same exit. Fundamentals are likely improving, so as positioning and valuation reset the trade can continue, but selectively. x.com 

Aehr Test Systems is gaining from accelerating AI chip production, since its machines test AI chips before they leave the factory, a check that matters more as chips grow costlier and more powerful. It reported record orders, a massive backlog and a big increase in cash, and guided for revenue to potentially nearly triple next year. Buying more testing equipment usually means manufacturers are preparing to build much more AI hardware. x.com  x.com 

Aehr Test Systems is a case of narrative running ahead of the numbers. The bull case is reasonable: a young company with a strong position in silicon carbide burn-in, genuine hyperscaler interest in AI chip burn-in and room to expand into memory and logic. But the latest quarter showed revenue down 43% year over year, with no meaningful order conversion from the AI opportunities yet. Until revenue improves and orders come through more clearly, the story stays ahead of the fundamentals. x.com 

Marvell, ServiceNow, Intel, Vertiv and Micron sit in the AI bottleneck, making them long-term investments. x.com 

AI bottleneck semiconductor stocks look to have gotten ahead of themselves, with roughly a hundred near-vertical charts where downside now seems to outweigh upside. They are semis and highly cyclical, and many smaller caps may end up trading like meme stocks. A substantial shakeout would offer a better entry. AI, robotics and energy still have years of growth ahead, but chasing these names now is not advisable. x.com  x.com  x.com  x.com  x.com 

Aehr Test Systems' valuation looks ahead of its fundamentals after a strong turnaround quarter. Q4 FY2026 revenue rose 33% to $18.8 million with a return to GAAP profit, bookings hit a record $60.7 million and effective backlog topped $100.6 million. FY2027 guidance of $130-150 million implies 160-200% growth, so the post-earnings run prices in high expectations that depend on shipping FOX-XP systems on schedule without margin erosion. TRT is preferred for now. x.com  x.com 

Semiconductor stocks' easy-money phase is over as the sector shifts from hype to show-me-the-money. The SOX index is down over 15% from its June peak, chip funds saw $11B of outflows in one week, the largest this century, short interest is at a three-year high and earnings growth is projected to slow by 2027. Memory and logic chips remain commodity-like. This is cyclical cooling, not a death knell; the AI build-out continues, but expect more turbulence and favor companies with defensive moats. … Show more